Recent Blog Posts

View Post: Clopidogrel response decreased with chronic renal failure ...
25 Nov 2009
NEW YORK (Reuters Health) - Chronic renal disease appears to reduce platelet responsiveness to clopidogrel, according to a Korean research team. Furthermore, increasing the dose of clopidogrel does not improve platelet responsiveness in ...
View Blog: The Doctor's Channel - http://www.thedoctorschannel.com/

---

View Post: Cardiovascular outcomes and mortality in patients using ...
24 Nov 2009
According to a study published early online in Circulation, although point estimates indicated a slightly increased risk of myocardial infarction hospitalisation or death in older patients initiating both clopidogrel and a proton pump ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: FDA Alert: Clopidogrel (marketed as Plavix) and Omeprazole ...
16 Nov 2009
FDA notified healthcare professionals of new safety information concerning an interaction between clopidogrel (Plavix), an anti-clotting medication, and omeprazole (Prilosec/Prilosec OTC), a proton pump inhibitor (PPI) used to reduce ...
View Blog: Drugs.com - FDA MedWatch Alerts - http://www.drugs.com/fda_alerts.html

---

View Post: Helm successfully defends European free-base clopidogrel patent
26 Nov 2009
The privately owned German chemical company Helm has successfully defended its European patent No 1592694 covering a free-base version of the oral antiplatelet agent clopidogrel. The opposition division of the European Patent Office ...
View Blog: Scrip News - Home - RSS - http://www.scripnews.com/home/

---

View Post: New warnings added to Plavix (clopidogrel) label « CardioBrief
16 Nov 2009 by Larry Husten  
Several new warnings have been added to the Plavix (clopidogrel) label. The new warnings are for reduced effectiveness due to impaired CYP2C19 function and for co-adminstration of the drug with omeprazole, which can reduce the ...
View Blog: CardioBrief - http://cardiobrief.org/

---

View Post: Effient(R) Exhibited Greater Antiplatelet Activity than High Dose ...
23 Nov 2009 by US  
In addition, one hour after the loading dose, patients who received Effient had 50 percent IPA compared with 13 percent in patients who received clopidogrel. The level of platelet inhibition achieved for each drug at four hours was ...
View Blog: US Post Today. - http://www.usposttoday.com/

---

View Post: Ticlopidine. Dipyridamole. Clopidogrel
26 Nov 2009 by Jammy B.  
Clopidogrel, a thienopyridine derivative similar to ticlopidine, is a new antiplatelet agent which is an inhibitor of platelet aggregation induced by adenosine diphosphate. This agent at a dose of 75 mg BID was recently compared to ...
View Blog: Diseases information. Disorders. Treatment. - http://www.diseasesinfoblog.com/

---